syngo REVEAL is a diffusion weighted imaging tool based on Echo Planar Imaging and can be combined with the free-breathing PACE (Prospective Acquisition CorrEction technique*). As the diffusion coefficient of the metastasis and primary tumors changes compared to normal tissue, syngo REVEAL uses diffusion contrast in the body in order to improve differential diagnosis.

In the abdominal region, studies indicate that benign lesions such as hemangiomas and focal nodular hyperplastic cysts show ADC coefficients. And malignant lesions such as hepatocellular carcinomas or metastases have a reduced ADC compared to benign lesions such as hemangiomas and focal nodular hyperplastic cysts. Malignant lesions also tend to have a marked decrease in ADC compared to inflammatory processes. These observations may apply not only to the abdomen but also to the rest of the body such as the pelvis, thorax, and more.

Lesions can be small and multi-focal. With syngo REVEAL at b-values of 800 and more, potential lesions are bright and easily distinguishable as the background is suppressed. The highlighted potential lesions can then easily be checked on images with other contrasts.

With its low b-values (sometimes called Dark Blood REVEAL with b ~ 50 s/mm2), as well as higher b-values (typically 1,000 s/mm2) syngo REVEAL can be used to obtain quantitative ADC maps by using Inline Technology for automatic ADC calculation at the end of the scan.

syngo REVEAL images can also be either inverted to produce a PET-like contrast or can be colorized and fused onto anatomical images using syngo Image Fusion.

syngo REVEAL works together with GRAPPA, Siemens unique Parallel Imaging algorithm which reduces susceptibility artifacts that might otherwise compromise image quality.

Now more than ever, all will be revealed to you with syngo REVEAL.